CoChat

Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective

Open access
Razavi, Zahra-Sadat, Soltani, Madjid, Mahmoudvand, Golnaz, Farokhi, Simin, Karimi-Rouzbahani, Arian, Farasati-Far, Bahareh, Tahmasebi-Ghorabi, Samaneh, Pazoki-Toroudi, Hamidreza, Afkhami, Hamed · 2024 · Frontiers in Bioengineering and Biotechnology

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Abstract

Myocardial infarction (MI) stands as a prominent contributor to global cardiovascular disease (CVD) mortality rates. Acute MI (AMI) can result in the loss of a large number of cardiomyocytes (CMs), which the adult heart struggles to replenish due to its limited regenerative capacity. Consequently, this deficit in CMs often precipitates severe complications such as heart failure (HF), with whole heart transplantation remaining the sole definitive treatment option, albeit constrained by inherent limitations. In response to these challenges, the integration of bio-functional materials within cardiac tissue engineering has emerged as a groundbreaking approach with significant potential for cardiac tissue replacement. Bioengineering strategies entail fortifying or substituting biological tissues through the orchestrated interplay of cells, engineering methodologies, and innovative materials. Biomaterial scaffolds, crucial in this paradigm, provide the essential microenvironment conducive to the assembly of functional cardiac tissue by encapsulating contracting cells. Indeed, the field of cardiac tissue engineering has witnessed remarkable strides, largely owing to the application of biomaterial scaffolds. However, inherent complexities persist, necessitating further exploration and innovation. This review delves into the pivotal role of biomaterial scaffolds in cardiac tissue engineering, shedding light on their utilization, challenges encountered, and promising avenues for future advancement. By critically examining the current landscape, we aim to catalyze progress toward more effective solutions for cardiac tissue regeneration and ultimately, improved outcomes for patients grappling with cardiovascular ailments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2024.1385124

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Diverse biomaterials driving innovation in cardiac tissue engineering: from engineered cardiac tissue to injectable hydrogels, patches, nanomaterials, and artificial vessels. ECM: Extracellular Matrix.
FIGURE 1 Diverse biomaterials driving innovation in cardiac tissue engineering: from engineered cardiac tissue to injectable hydrogels, patches, nanomaterials, and artificial vessels. ECM: Extracellular Matrix.CC BY · PubMed Central
FIGURE 2 Pathophysiology of acute coronary syndrome (ACS).
FIGURE 2 Pathophysiology of acute coronary syndrome (ACS).CC BY · PubMed Central
FIGURE 3 Aspects of scaffold which consider in tissue engineering.
FIGURE 3 Aspects of scaffold which consider in tissue engineering.CC BY · PubMed Central
FIGURE 4 Process of 3D bioprinting, (A) steps of 3D bioprinting, (B) pre-scaffold fabrication bioprinting, (C) simultaneous hybrid 3D bioprinting (Qasim et al., 2019)
FIGURE 4 Process of 3D bioprinting, (A) steps of 3D bioprinting, (B) pre-scaffold fabrication bioprinting, (C) simultaneous hybrid 3D bioprinting (Qasim et al., 2019)CC BY · PubMed Central
FIGURE 5 Cardiac extra cellular matrix and properties.
FIGURE 5 Cardiac extra cellular matrix and properties.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 142 references

Research works printed but not linked: 2

  1. Majid, Natural biomaterials for cardiac tissue engineering: a highly biocompatible solution, Front. Cardiovasc. Med., 7, 554597, 10.3389/fcvm.2020.554597 · DOI · Paper page
  2. Roacho-Perez, 2022, Artificial scaffolds in cardiac tissue engineering, Life (Basel), 12, 1117, 10.3390/life12081117 · DOI

Cited by

See all 64

Metadata

Authors
Razavi, Z.-S., Soltani, M., Mahmoudvand, G., Farokhi, S., Karimi-Rouzbahani, A., Farasati-Far, B., Tahmasebi-Ghorabi, S., Pazoki-Toroudi, H., & Afkhami, H.
Affiliations
  • Iran University of Medical Sciences (IR)
  • University of Waterloo (CA)
  • Lorestan University of Medical Sciences (IR)
  • Shahed University (IR)
Corresponding author
Afkhami, Hamed
Venue
Frontiers in Bioengineering and Biotechnology
Published
2024-05-31
Volume
12
Pages
1385124-1385124
ISSN
2296-4185 (ISSN-L)
OpenAlex
W4399246503
Cited by
64
References
142
Citations by year
2026: 20 · 2025: 30 · 2024: 14
FWCI
7.09
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
Keywords
cardiac tissue engineering, biomaterial scaffolds, myocardial infarction, cardiomyocyte regeneration, heart failure, cardiac regeneration, cardiovascular disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective. https://app.cochat.ai/papers/10.3389/fbioe.2024.1385124
The paper
Razavi, Z.-S., Soltani, M., Mahmoudvand, G., Farokhi, S., Karimi-Rouzbahani, A., Farasati-Far, B., Tahmasebi-Ghorabi, S., Pazoki-Toroudi, H., & Afkhami, H. (2024). Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2024.1385124

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.